Brick & Kyle Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Brick & Kyle Associates's BMY Position: Q1 2026 in Review
Brick & Kyle Associates opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 20,796 shares worth $1.26M. The stake represents 0.42% of the portfolio and ranks #44 among its holdings. This is a return to the name: Brick & Kyle Associates previously reported a position in BMY as recently as Q4 2018.
Brick & Kyle Associates first reported a position in BMY in Q4 2014 and has held it in 17 quarters since. The position peaked at $4.3M in Q2 2016. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Brick & Kyle Associates held 20,796 shares of Bristol-Myers Squibb worth $1.26M as of Q1 2026.
- Bristol-Myers Squibb was a new Brick & Kyle Associates position in Q1 2026.
- Bristol-Myers Squibb made up 0.42% of Brick & Kyle Associates's portfolio in Q1 2026, its #44 holding.
- Brick & Kyle Associates first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 17 quarters since.
- Brick & Kyle Associates's Bristol-Myers Squibb position peaked at $4.3M in Q2 2016.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Brick & Kyle Associates's 13F filing for Q1 2026, filed 2 Jul 2026.